Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit
Amgen Inc. (NASDAQ: AMGN) is holding up better than some investors might have expected after the biotech giant warned about earnings. The lowering of earnings estimates was by a mere ...Read Full Story »
